Chapter 14

  1. Abd-Eldaim MM, Wilkes RP, Thomas KV, et al. 2009. Development and validation of a TaqMan real-time reverse transcription-PCR for rapid detection of feline calicivirus. Arch Virol 154:555-560.
  2. Addie D, Poulet H, Golder MC. 2008. Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK. Vet Rec 163:355-557.
  3. Bannasch MJ, Foley JE. 2005. Epidemiologic evaluation of multiple respiratory pathogens in cats in animal shelters. J Feline Med Surg 7:109-119.
  4. Baulch-Brown C, Love DN, Meanger J. 1999. Sequence variation within the capsid protein of Australian isolates of feline calicivirus isolates. Vet Microbiol 68:107-117.
  5. Bergman JGHE, Vernooij J, Zegers EM. 1997. Prevalence of antibodies against Bordetella bronchiseptica in cats with a history of respiratory disease. Vet Q 19(Suppl 1):S50.
  6. Binns SH, Dawson S, Speakman AJ, et al. 1999. Prevalence and risk factors for feline Bordetella bronchiseptica infection. Vet Rec 144:575-580.
  7. Binns SH, Dawson S, Speakman AJ, et al. 2000. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. J Fel Med Surg 2:123-133.
  8. Binns SH, Speakman AJ, Dawson S, et al. 1998. The use of pulse-field electrophoresis to examine the epidemiology of Bordetella bronchiseptica isolated from cats and other species. Epidemiol Infect 120:201-208.
  9. Burgesser KM, Hotaling S, Schiebel A, et al. 1999. Comparison of PCR, virus isolation, and indirect fluorescent antibody staining in the detection of naturally occurring feline herpesvirus infections, J Vet Diagn Invest 11:122-126.
  10. Cai Y, Fukushi H, Koyasu S, et al. 2002. An etiological investigation of domestic cats with conjunctivitis and upper respiratory tract disease in Japan. J Vet Med Sci 64:215-219.
  11. Camero M, Cirone F, Bozzo G, et al. 2002. Serological analysis and identification of feline calicivirus strains isolated in Sicily. New Microbiol 25:243-246.
  12. Carbone M, Pennisi MG, Masucci M, et al. 2001. Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates. Vet Microbiol 81:79-84.
  13. Chandler JC, Lappin MR. 2002. Mycoplasmal respiratory infections in small animals: 17 cases (1988-1999). J Am Anim Hosp Assoc 38:111-119.
  14. Collins BK. 2002. Treatment of feline ocular herpesvirus infections: a review. Adv Small Anim Med Surg 15:1-3.
  15. Coutts AJ, Dawson S, Binns S, et al. 1996. Studies on natural transmission of Bordetella bronchiseptica in cats. Vet Microbiol 48:19-27.
  16. Coyne KP, Dawson S, Radford AD, et al. 2006. Long-term analysis of feline calicivirus prevalence and viral shedding patterns in naturally infected colonies of domestic cats. Vet Microbiol 118:12-25.
  17. Coyne KP, Edwards D, Radford AD, et al. 2007. Longitudinal molecular epidemiological analysis of feline calicivirus infection in an animal shelter: a model for investigating calicivirus transmission within high-density, high-turnover populations. J Clin Microbiol 45:3239-3244.
  18. Coyne KP, Gaskell RM, Dawson S, et al. 2007. Evolutionary mechanisms of persistence and diversification of a calicivirus within endemically infected natural host populations. J Virol 81:1961-1971.
  19. Coyne KP, Jones BR, Kipar A, et al. 2006. Lethal outbreak of disease associated with feline calicivirus infection in cats. Vet Rec 158: 544-550.
  20. Daniels WJ, Golder MC, Jarrett O, et al. 1999. Feline viruses in wildcats from Scotland. J Wildl Dis 35:121-124.
  21. Dawson S, Bennett D, Carter SD, et al. 1994. Acute arthritis of cats associated with feline calicivirus infection. Res Vet Sci 56:133-143.
  22. Dawson S, Jones D, McCracken CM, et al. 2000. Bordetella bronchiseptica infection in cats following contact with infected dogs. Vet Rec 146:46-48.
  23. Dawson S, McArdle F, Bennett M, et al. 1993. Typing of feline calicivirus isolates from different clinical groups by virus neutralisation tests. Vet Rec 133:13-17.
  24. Dawson S, Smyth NR, Bennett M, et al. 1991. Effect of primary-stage feline immunodeficiency virus infection on subsequent feline calicivirus vaccination and challenge in cats. AIDS 5:747-750.
  25. Dawson S, Willoughby K, Gaskell RM, et al. 2001. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens, J Feline Med Surg 3:17-22.
  26. Day MJ, Horzinek MC, Schultz RD. 2010. Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). J Small Anim Pract 51:338-356. Full guidelines available at http://www.wsava.org/PDF/Misc/VaccinationGuidelines2010.
  27. Day MJ, Schoon HA, Magnol JP, et al. 2007. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine 25:4073-4084.
  28. DeSilver DA, Guimond PM, Gibson JK, et al. 1997. Expression of the complete capsid and the hypervariable region of feline calicivirus in the baculovirus expression system, pp 131-143. In Chasey D, Gaskell RM, Clarke IN (eds): First international symposium on caliciviruses. Proc Eur Soc Vet Virol (ESVV) Symp, ESVV and Central Veterinary Laboratory.
  29. Di Martino B, Di Francesco CE, Meridiani I, et al. 2007. Etiological investigation of multiple respiratory infections in cats. New Microbiol 30:455-461.
  30. Di Martino B, Di Rocco C, Ceci C, et al. 2009. Characterization of a strain of feline calicivirus isolated from a dog faecal sample. Vet Microbiol 139:52-57.
  31. Drazenovich TL, Fascetti AJ, Westermeyyer HD, et al. 2009. Effects of dietary lysine supplementation on upper respiratory and ocular disease and detection of infectious organisms in cats within an animal shelter. Am J Vet Res 70:1391-1400.
  32. Driciru M, Siefert L, Prager KC, et al. 2006. A serosurvey of viral infections in lions (Panthera leo), from Queen Elizabeth National Park, Uganda. J Wildl Dis 42:667-671.
  33. Edinboro CH, Janowitz LK, Guptill-Yoran L, et al. 1999. A clinical trial of intranasal and subcutaneous vaccines to prevent upper respiratory infection in cats at animal shelter. Feline Pract 27:7-13.
  34. Edwards DS, Coyne K, Dawson S, et al. 2008. Risk factors for time to diagnosis of feline upper respiratory tract disease in UK animal adoption shelters. Prev Vet Med 87:327-339.
  35. Egberink H, Addie D, Belák S, et al. 2009. Bordetella bronchiseptica infection in cats. ABCD guidelines on prevention and management. J Feline Med Surg 11:610-614. Full guidelines available at http://www.abcd-vets.org/guidelines/index.asp. Accessed 5/21/11.
  36. Eleraky NZ, Potgieter LN, Kennedy MA. 2002. Virucidal efficacy of four new disinfectants. J Am Anim Hosp Assoc 38:231-234.
  37. Elston T, Rodan H, Flemming D, et al. 1998. 1998 report of the American Association of Feline Practitioners and Academy of Feline Medicine Advisory Panel on Feline Vaccines. J Am Vet Med Assoc 212:227-241.
  38. Elston T, Rodan I, Flemming D, et al. 1998. Feline vaccine guidelines—from the Advisory Panel on Feline Vaccines. Feline Pract 26:14-16.
  39. Foley J. 2002. Calicivirus, haemorrhagic, feline—USA. ProMED-mail 2002; 14 July: 20020714.4757. www.promedmail.org. Accessed 4/19/10.
  40. Foley JE, Rand C, Bannasch MJ, et al. 2002. Molecular epidemiology of feline bordetellosis in two animal shelters in California, USA. Prev Vet Med 54:141-156.
  41. Fontenelle JP, Powell CC, Veir JK, et al. 2008. Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. Am J Vet Res 69:289-293.
  42. Foster SF, Barrs VR, Martin P, et al. 1998. Pneumonia associated with Mycoplasma spp. in three cats. Aust Vet J 76:460-464.
  43. Foster SF, Martin P, Braddock JA, et al. 2004. A retrospective analysis of feline bronchoalveolar lavage cytology and microbiology (1995-2000). J Feline Med Surg 6:189-198.
  44. Gaskell R, Dawson S, Radford A, et al. 2007. Feline herpesvirus. Vet Res 38:337-354.
  45. Gaskell R, Willoughby K. 1999. Herpesviruses of carnivores. Vet Microbiol 69:73-88.
  46. Gaskell RM, Dawson SD. 1998. Feline respiratory disease, pp 97-106. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2, WB Saunders, Philadelphia.
  47. Gaskell RM, Dawson S, et al. 2009. Other feline virus diseases. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine. Elsevier Saunders, St Louis.
  48. Gaskell RM, Gettinby G, Graham SJ, et al. 2002. Veterinary Products Committee (VPC) working group report on feline and canine vaccination. Final report to the VPC. Departmental for Environmental, Food and Rural Affairs, PB 6432, London.
  49. Gaskell RM, Gettinby G, Graham SJ, et al. 2002. Veterinary Products Committee working group report on feline and canine vaccination. Vet Rec 150:126-134.
  50. Gaskell RM, Radford AD, Dawson S. 2004. Feline infectious respiratory disease, pp 577-595. In Chandler EA, Gaskell CJ, Gaskell RM (eds): Feline medicine and therapeutics, ed 3, Blackwell Publishing, Oxford.
  51. Geissler K, Schneider K, Platzer G, et al. 1997. Genetic and antigenic heterogeneity among feline calicivirus isolates from distinct disease manifestations. Virus Res 48:193-206.
  52. Gerhardt N, Schulz S, Werckenthin C, et al. 2006. Pharmacokinetics of enrofloxacin and its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. Vet Rec 159:591-594.
  53. Glenn M, Radford AD, Turner PC, et al. 1999. Nucleotide sequence of UK and Australian isolates of feline calicivirus (FCV) and phylogenetic analysis of FCVs. Vet Microbiol 67:175-193.
  54. Gore TC, Lakshmanan N, Williams JR, et al. 2006. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus. Vet Ther 7:213-222.
  55. Haesebrouck F, Devriese LA, van Rijssen B, et al. 1991. Incidence and significance of isolation of Mycoplasma felis from conjunctival swabs of cats. Vet Microbiol 26:95-101.
  56. Haid C, Kaps S, Gönczi E, et al. 2007. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats. Vet Ophthalmol 10:278-284.
  57. Hamano M, Maeda K, Kai K, et al. 2005. A novel genetic marker to differentiate feline herpesvirus type 1 field isolates. Vet Microbiol 106:195-200.
  58. Hamano M, Maeda K, Mizukoshi F, et al. 2003. Experimental infection of recent field isolates of feline herpesvirus type 1. J Vet Med Sci 65:939-943.
  59. Hamano M, Maeda K, Mizukoshi F, et al. 2004. Genetic rearrangements in the gC gene of the feline herpesvirus type 1. Virus Genes 28:55-60.
  60. Hargis AM, Ginn PE. 1999. Feline herpesvirus 1-associated facial and nasal dermatitis and stomatitis in domestic cats. Vet Clin North Am Small Anim Pract 29:1281-1290.
  61. Hargis AM, Ginn PE, Mansell JEKL, et al. 1999. Ulcerative facial and nasal dermatitis and stomatitis in cats associated with feline herpesvirus 1. Vet Dermatol 10:267-274.
  62. Harrison TM, Sikarskie S, Kruger J, et al. 2007. Systemic calicivirus epidemic in captive exotic felids. J Zoo Wildl Med 38:292-299.
  63. 62a. Hartmann AD, Hawley J, Werckenthin C, et al. 2010. Detection of bacterial and viral organisms from the conjunctiva of cats with conjunctivitis and upper respiratory tract disease. J Feline Med Surg 12:755-782.
  64. Hartmann AD, Helps CR, Lappin MR, et al. 2008. Efficacy of pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or Mycoplasma infections. J Vet Intern Med 22: 44-52.
  65. Hashimoto M, Roerink F, Tohya Y, et al. 1999. Genetic analysis of the RNA polymerase gene of caliciviruses from dogs and cats. J Vet Med Sci 61:603-608.
  66. Healey KA, Dawson S, Burrows R, et al. 2007. Prevalence of feline chronic gingivo-stomatitis in first opinion veterinary practice. J Feline Med Surg 9:373-381.
  67. Helps C, Lait P, Tasker S, et al. 2002. Melting curve analysis of feline calicivirus isolates detected by real-time reverse transcription PCR. J Virol Methods 106:241-244.
  68. Helps CR, Lait P, Damhuis A, et al. 2005. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec 156:669-673.
  69. Hickman MA, Reubel GH, Hoffman DE, et al. 1994. An epizootic of feline herpesvirus, type 1 in a large specific pathogen-free cat colony and attempts to eradicate the infection by identification and culling of carriers. Lab Anim 28:320-329.
  70. Hohdatsu T, Sato K, Tajima T, et al. 1999. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates. J Vet Med Sci 61:299-301.
  71. Holland JL, Outerbridge CA, Affolter VR, et al. 2006. Detection of feline herpesvirus 1 DNA in skin biopsy specimens from cats with or without dermatitis. J Am Vet Med Assoc 229:1442-1446.
  72. 70a. Holst BS, Hanas S, Berndtsson LT, et al. 2010. Infectious causes for feline upper respiratory disease—a case-control study. J Feline Med Surg 12:783-789.
  73. Hoppe JE, Bryskier A. 1998. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647) four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). Antimicrob Agents Chemother 42:965-966.
  74. Horimoto T, Takeda Y, Iwatsuki-Horimoto K, et al. 2001. Capsid protein gene variation among feline calicivirus isolates. Virus Genes 23:171-174.
  75. Hoskins J, Richards J, Rayne EM, et al. 1999. Roundtable discussion: feline Bordetella bronchiseptica, part 1. Feline Pract 27:10-12.
  76. Hoskins JD, Williams J, Roy AF, et al. 1998. Isolation and characterization of Bordetella bronchiseptica from cats in southern Louisiana. Vet Immunol Immunopathol 65:173-176.
  77. Huang C, Hess J, Gill M, et al. 2010. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease. J Feline Med Surg 12:129-137.
  78. Hurley KF, Pesavento PA, Pedersen NC, et al. 2004. An outbreak of virulent systemic feline calicivirus disease. J Am Vet Med Assoc 224:241-249.
  79. Hussein IT, Menashy RV, Field HJ. 2008. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase. Antiviral Res 78:268-274.
  80. Iglauer F, Gartner K, Moerstedt R, et al. 1989. Maternal protection against feline respiratory disease by means of booster vaccinations during pregnancy—a retrospective clinical study. Kleintierpraxis 34: 235-242.
  81. Jacobs AAC, Chalmers WSK, Pasman J. 1993. Feline bordetellosis: challenge and vaccine studies. Vet Rec 133:260-263.
  82. Jas D, Aeberle C, Lacombe V, et al. 2009. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus. Vet J 182:86-93.
  83. Johnson LR, Foley JE, DeCock HE, et al. 2005. Assessment of infectious organisms associated with chronic rhinosinusitis in cats. J Am Vet Med Assoc 227:579-585.
  84. Johnson LR, Kass PH. 2009. Effect of sample collection methodology on nasal culture results in cats. J Feline Med Surg 11: 645-649.
  85. Kadoi K, Kiryu M, Iwabuchi M, et al. 1997. A strain of calicivirus isolated from lions with vesicular lesions on tongue and snout. New Microbiol 20:141-148.
  86. Kang BT, Park HM. 2008. Prevalence of feline herpesvirus 1, feline calicivirus and Chlamydophila felis in clinically normal cats at a Korean animal shelter. J Vet Sci 9:207-209.
  87. 84a. Klose TC, MacPhail CM, Schultheiss PC, et al. 2010. Prevalence of select infectious agents in inflammatory aural and nasopharyngeal polyps from client-owned cats. J Feline Med Surg 12:769-774.
  88. Knowles JO, McArdle F, Dawson S, et al. 1991. Studies on the role of feline calicivirus in chronic stomatitis in cats. Vet Microbiol 27:205-219.
  89. Kreutz LC, Johnson RP, Seal BS. 1998. Phenotypic and genotypic variation of feline calicivirus during persistent infection of cats. Vet Microbiol 59:229-236.
  90. Lappin MR, Andrews J, Simpson D, et al. 2002. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats. J Am Vet Med Assoc 220:38-42.
  91. Lappin MR, Sebring RW, Porter M, et al. 2006. Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1. J Feline Med Surg 8:158-163.
  92. Lappin MR, Veir J, Howley J. 2009. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines. J Feline Med Surg 11:159-162.
  93. Lauritzen A, Jarrett O, Sabara M. 1997. Serological analysis of feline calicivirus isolates from the United States and United Kingdom. Vet Microbiol 56:55-63.
  94. Lee M, Bosward KL, Norris JM. 2010. Immunohistochemical evaluation of feline herpesvirus-1 infection in feline eosinophilic dermatoses or stomatitis. J Feline Med Surg 12:72-79.
  95. Little S. 2000. Bordetella bronchiseptica infection in a cat. Feline Pract 28:12-17.
  96. Macy DW. 1999. Current understanding of vaccination site-associated sarcomas in the cat. J Feline Med Surg 1:15-21.
  97. 93a. Maggs DJ. 2010. Antiviral therapy for feline herpesvirus infections.Vet Clin Small Anim 40:1055-1062.
  98. Maggs DJ, Clarke HE. 2004. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res 65:399-403.
  99. Maggs DJ, Clarke HE. 2005. Relative sensitivity of polymerase chain reaction assays used for detection of feline herpesvirus type 1 DNA in clinical samples and commercial vaccines. Am J Vet Res 66:1550-1555.
  100. Maggs DJ, Collins BK, Thorne JG, et al. 2000. Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1. Am J Vet Res 61:1474-1478.
  101. Maggs DJ, Lappin MR, Nasisse MP. 1999. Detection of feline herpesvirus-specific antibodies and DNA in aqueous humor from cats with or without uveitis. Am J Vet Res 60:932-936.
  102. Maggs DJ, Lappin MR, Reif JS, et al. 1999. Evaluation of serologic and viral detection methods for diagnosing feline herpesvirus-1 infection in cats with acute respiratory tract or chronic ocular disease. J Am Vet Med Assoc 214:502-507.
  103. Maggs DJ, Nasisse MP, Kass PH. 2003. Efficacy of oral supplementation with L-lysine in cats latently infected with feline herpesvirus. Am J Vet Res 64:37-42.
  104. Maggs DJ, Sykes JE, Clarke HE, et al. 2007. Effects of dietary lysine supplementation in cats with enzootic upper respiratory disease. J Feline Med Surg 9:97-108.
  105. Malik R, Lessels NS, Webb S, et al. 2009. Treatment of feline herpesvirus-1 associated disease in cats with famciclovir and related drugs. J Feline Med Surg 11:40-48.
  106. Marsilio F, Martino BD, Decaro N, et al. 2005. A novel nested PCR for the diagnosis of calicivirus infections in the cat. Vet Microbiol 105:1-7.
  107. Martella V, Pratelli A, Gentile M, et al. 2002. Analysis of the capsid protein gene of a feline-like calicivirus isolated from a dog. Vet Microbiol 85:315-322.
  108. Martina BE, Airikkala MI, Harder TC, et al. 2001. A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection. Vaccine 20:943-948.
  109. 104a. Masubuchi K, Wakatsuki A, Iwamoto K, et al. 2010. Immunological and genetic characterization of feline caliciviruses used in the development of a new trivalent inactivated vaccine in Japan. J Vet Med Sci 72:1189-1194.
  110. Matsuura Y, Tohya Y, Nakamura K, et al. 2002. Complete nucleotide sequence, genome organization and phylogenic analysis of the canine calicivirus. Virus Genes 25:67-73.
  111. McCabe VJ, Tarpey I, Spibey N. 2002. Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein. Vaccine 20:2454-2462.
  112. McGrotty YL, Knottenbelt CM. 2002. Oesophageal stricture in a cat due to administration of tetracyclines. J Small Anim Pract 43:221-223.
  113. Melendez LD, Twedt DC, Wright M. 2000. Suspected doxycycline-induced esophagitis with esophageal stricture formation in three cats. Feline Pract 28:10-12.
  114. Mencke N, Vobis M, Mehlhorn H, et al. 2009. Transmission of feline calicivirus via the cat flea (Ctenocephalides felis). Parasitol Res 105:185-189.
  115. Mochizuki M, Kawakami K, Hashimoto M, et al. 2000. Recent epidemiological status of feline upper respiratory infections in Japan. J Vet Med Sci 62:801-803.
  116. Mochizuki M, Nakatani H, Yoshida M. 1994. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet Microbiol 39:145-152.
  117. Molyneux JM, Guilford WG, Hunter JE, et al. 2000. Prevalence of Bordetella bronchiseptica in cats attended by a veterinary practice in the Manawatu region. N Z Vet J 48:82-84.
  118. Morrison WB, Starr RM. 2001. Vaccine-associated feline sarcomas. J Am Vet Med Assoc 218:697-702.
  119. Mouzin DE, Lorenzen MJ, Haworth JD, et al. 2004. Duration of serologic response to three viral antigens in cats. J Am Vet Med Assoc 224:61-66.
  120. Munson L, Wack R, Duncan M, et al. 2004. Chronic eosinophilic dermatitis associated with persistent feline herpes virus infection in cheetahs (Acinonyx jubatus). Vet Pathol 41:170-176.
  121. Nasisse MP, Dorman DC, Jamison KC, et al. 1997. Effects of valacyclovir in cats infected with feline herpesvirus 1. Am J Vet Res 58:1141-1144.
  122. Nasisse MP, English RV, Tompkins MB, et al. 1995. Immunologic, histologic, and virologic features of herpesvirus-induced stromal keratitis in cats. Am J Vet Res 56:51-55.
  123. Nasisse MP, Glover TL, Moore CP, et al. 1998. Detection of feline herpesvirus 1 DNA in corneas of cats with eosinophilic keratitis or corneal sequestration. Am J Vet Res 59:856-858.
  124. Nasisse MP, Guy JS, Davidson MG, et al. 1989. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine. Am J Vet Res 50:158-160.
  125. Nasisse MP, Halenda RM, Luo H. 1996. Efficacy of low dose oral, natural human interferon alpha in acute feline herpesvirus-1 (FHV-1) infection: a preliminary dose determination trial, p 79. In Proceedings of the 27th Annual Meeting of the American College of Veterinary Ophthalmologists.
  126. Ohe K, Takahashi T, Hara D, et al. 2008. Sensitivity of FCV to recombinant feline interferon (rFeIFN). Vet Res Commun 32:167-174.
  127. Ossiboff RJ, Sheh A, Shotton J, et al. 2007. Feline caliciviruses (FCVs) isolated from cats with virulent systemic disease possess in vitro phenotypes distinct from those of other FCV isolates. J Gen Virol 88:506-517.
  128. Owen WM, Sturgess CP, Harbour DA, et al. Efficacy of azithromycin for the treatment of feline chlamydophilosis. J Fel Med Surg 2003: 5: 305-311.
  129. Parzefall B, Schmahl W, Fischer A, et al. 2010. Evidence of feline herpesvirus-1 DNA in the vestibular ganglion of domestic cats. Vet J 184:371-372.
  130. Pasmans F, Acke M, Vanrobaeys M, et al. 2001. Prevalence of Bordetella bronchiseptica infections in cats from different environments. Vlaams Diergeneeskundig Tijdschr 70:124-126.
  131. Pedersen NC, Elliott JB, Glasgow A, et al. 2000. An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus. Vet Microbiol 73:281-300.
  132. Pedersen NC, Hawkins KF. 1995. Mechanisms of persistence of acute and chronic feline calicivirus infections in the face of vaccination. Vet Microbiol 47:141-156.
  133. Pedersen NC, Sato R, Foley JE, et al. 2004. Common virus infections in cats, before and after being placed in shelters, with emphasis on feline enteric coronavirus. J Feline Med Surg 6:83-88.
  134. Pesavento PA, Chang KO, Parker JSL. 2008. Molecular virology of feline calicivirus. Vet Clin North Am Small Anim Pract 38:775-786, vii.
  135. Pesavento PA, MacLachlan NJ, Dillard-Telm L, et al. 2004. Pathologic, immunohistochemical, and electron microscopic findings in naturally occurring virulent systemic feline calicivirus infection in cats. Vet Pathol 41:257-263.
  136. Porter CJ, Radford AD, Gaskell RM, et al. 2008. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates. J Feline Med Surg 10:32-40.
  137. Poulet H. 2007. Alternative early life vaccination programs for companion animals. J Comp Pathol 137(Suppl 1): S67-S71.
  138. Poulet H, Brunet S, Leroy V, et al. 2005. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges. Vet Microbiol 106:17-31.
  139. Poulet H, Brunet S, Soulier M, et al. 2000. Comparison between acute oral/respiratory and chronic stomatitis/gingivitis isolates of feline calicivirus: pathogenicity, antigenic profile and cross-neutralisation studies. Arch Virol 145:243-261.
  140. Poulet H, Jas D, Lemeter C, et al. 2008. Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo. Vaccine 26: 3647-3654.
  141. Povey RC. 1978. Effect of orally administered ribavirin on experimental feline calicivirus infection in cats. Am J Vet Res 39:1337-1341.
  142. Povey RC. 1978. In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus. Am J Vet Res 39:175-178.
  143. Pratelli A, Tempesta M, De Palma MG, et al. 1999. Restriction endonuclease analysis of feline herpesvirus 1 DNA isolated from wild felids. Vet Rec 144:537-538.
  144. Radford AD, Addie D, Belák S, et al. 2009. Feline calicivirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 11:556-564. Full guidelines available at http://www.abcd-vets.org/guidelines/index.asp. Accessed 5/21/11.
  145. Radford AD, Bennett M, McArdle F, et al. 1997. The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures. Vaccine 15:1451-1458.
  146. Radford AD, Coyne KP, Dawson S, et al. 2007. Feline calicivirus. Vet Res 38:319-335.
  147. Radford AD, Dawson S, Wharmby C, et al. 2000. Comparison of serological and sequence-based methods for typing feline calicivirus isolates from vaccine failures. Vet Rec 146:117-123.
  148. Radford AD, Sommerville LM, Dawson S, et al. 2001. Molecular analysis of isolates of feline calicivirus from a population of cats in a rescue shelter. Vet Rec 149:477-481.
  149. Radford AD, Sommerville L, Ryvar R, et al. 2001. Endemic infection of a cat colony with a feline calicivirus closely related to an isolate used in live attenuated vaccines. Vaccine 19:4358-4362.
  150. Radford AD, Turner PC, Bennett M, et al. 1998. Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and in persistently infected cats. J Gen Virol 79:1-10.
  151. Randolph JF, Moise NS, Scarlett JM, et al. 1993. Prevalence of mycoplasmal and ureaplasmal recovery from tracheobronchial lavages and of mycoplasmal recovery from pharyngeal swab specimens in cats with or without pulmonary disease. Am J Vet Res 54:897-900.
  152. Reade B, Bowers RG, Begon M, et al. 1998. A model of disease and vaccination for infections with acute and chronic phases. J Theoretical Biol 190:355-367.
  153. Rees TM, Lubinski JL. 2008. Oral supplementation with L-lysine did not prevent upper respiratory infection in a shelter population of cats. J Feline Med Surg 10: 510-513.
  154. Reese MJ, Patterson EV, Tucker SJ, et al. 2008. Effects of anesthesia and surgery on serologic responses to vaccination in kittens. J Am Vet Med Assoc 233:116-121.
  155. Reubel GH, George JW, Barlough JE, et al. 1992. Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats. Vet Immunol Immunopathol 35:95-119.
  156. Reubel GH, George JW, Higgins J, et al. 1994. Effect of chronic feline immunodeficiency virus infection on experimental feline calicivirus-induced disease. Vet Microbiol 39:335-351.
  157. Reubel GH, Hoffmann DE, Pedersen NC. 1992. Acute and chronic faucitis of domestic cats: a feline calicivirus induced disease. Vet Clin North Am Small Anim Pract 22:1347-1360.
  158. Reubel GH, Ramos RA, Hickman MA, et al. 1993. Detection of active and latent feline herpesvirus 1 infections using the polymerase chain reaction. Arch Virol 132:409-420.
  159. Reynolds BS, Poulet H, Pingret JL, et al. 2009. A nosocomial outbreak of feline calicivirus associated virulent systemic disease in France. J Feline Med Surg 11:633-644.
  160. Richards JR, Elston TH, Ford RB, et al. 2006. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report. J Am Vet Med Assoc 229:1405-1441. Available at http://www.catvets.com/uploads/PDF/2006_Vaccination_Guidelines_JAVMA_Plus.pdf. Accessed 5/21/11.
  161. Roerink F, Hashimoto M, Tohya Y, et al. 1999. Genetic analysis of a canine calicivirus: evidence for a new clade of animal caliciviruses. Vet Microbiol 69:69-72.
  162. Sandmeyer LS, Keller CB, Bienzle D. 2005. Effects of cidofovir on cell death and replication of feline herpesvirus-1 in cultured feline corneal epithelial cells. Am J Vet Res 66:217-222.
  163. Sandmeyer LS, Keller CB, Bienzle D. 2005. Effects of interferon-alpha on cytopathic changes and titers for feline herpesvirus-1 in primary cultures of feline corneal epithelial cells. Am J Vet Res 66:210-216.
  164. 158a. Sandmeyer LS, Waldner CL, Bauer BS, et al. 2010. Comparison of polymerase chain reaction tests for diagnosis of feline herpesvirus, Chlamydophila felis and Mycoplasma spp. infection in cats with ocular disease in Canada. Can Vet J 51:629-633.
  165. Sangabriel MCS, Tohya Y, Mochizuki M. 1996. Isolation of a calicivirus antigenically related to feline calicivirus from feces of a dog with diarrhea. J Vet Med Sci 58:1041-1043.
  166. Sato Y, Ohe K, Murakami M, et al. 2002. Phylogenetic analysis of field isolates of feline calicivirus (FCV) in Japan by sequencing part of its capsid gene. Vet Res Commun 26:205-219.
  167. Scansen BA, Wise AG, Kruger JM, et al. 2004. Evaluation of a p30 gene-based real-time reverse transcriptase polymerase chain reaction assay for detection of feline caliciviruses. J Vet Intern Med 18:135-138.
  168. Schorr-Evans EM, Poland A, Pedersen NC. 2003. An epizootic of highly virulent feline calicivirus disease in a hospital setting in New England. J Feline Med Surg 5:217-226.
  169. Scott FW, Geissinger CM. 1997. Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus and calicivirus vaccine. Feline Pract 25:12-19.
  170. Scott FW, Geissinger CM. 1999. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am J Vet Res 60:652-658.
  171. Siebeck N, Hurley DJ, Garcia M, et al. 2006. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1. Am J Vet Res 67:1406-1411.
  172. 165a. Smith AW, Iversen PL, O’Hanley PD, et al. 2008. Virus-specific antiviral treatment for controlling severe and fatal outbreaks of feline calicivirus infection. Am J Vet Res 69:23-32.
  173. Sommerville LM, Radford AD, Glenn M, et al. 2002. DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein. Vaccine 20:1787-1796.
  174. Sparkes A. 2010. Feline vaccination protocols: is a consensus emerging? Schweiz Arch Tierheilkd 152:135-140.
  175. Speakman AJ, Binns SH, Dawson S, et al. 1997. Antimicrobial susceptibility of Bordetella bronchiseptica isolates from cats and a comparison of the agar dilution and E-test methods. Vet Microbiol 54:63-72.
  176. Speakman AJ, Dawson S, Binns SH, et al. 1999. Bordetella bronchiseptica infection in the cat. J Small Anim Pract 40:252-256.
  177. Spindel ME, Veir JK, Radecki SV, et al. 2008. Evaluation of pradofloxacin for the treatment of feline rhinitis. J Feline Med Surg 10:472-479.
  178. Stiles J. 1995. Treatment of cats with ocular disease attributable to herpesvirus infection: 17 cases (1983-1993). J Am Vet Med Assoc 207:599-603.
  179. Stiles J. 2000. Feline herpesvirus. Vet Clin North Am Small Anim Pract 30:1001-1014.
  180. 172a. Stiles J, Gwin W, Pogranichniy R. 2010. Stability of 0.5% cidofovir stored under various conditions for up to 6 months. Vet Ophthalmol 13:275-277.
  181. Stiles J, McDermott M, Bigsby D, et al. 1997. Use of nested polymerase chain reaction to identify feline herpesvirus in ocular tissue from clinically normal cats and cats with corneal sequestra or conjunctivitis. Am J Vet Res 58:338-342.
  182. Stiles J, McDermott M, Willis M, et al. 1997. Comparison of nested polymerase chain reaction, virus isolation, and fluorescent antibody testing for identifying feline herpesvirus in cats with conjunctivitis. Am J Vet Res 58:804-807.
  183. Stiles J, Townsend WM, Rogers QR, et al. 2002. Effect of oral administration of L-lysine on conjunctivitis caused by feline herpesvirus in cats. Am J Vet Res 63:99-103.
  184. Sykes JE, Anderson GA, Studdert VP, et al. 1999. Prevalence of feline Chlamydia psittaci and feline herpesvirus 1 in cats with upper respiratory tract disease. J Vet Intern Med 13:153-162.
  185. Sykes JE, Browning GF, Anderson G, et al. 1997. Differential sensitivity of culture and the polymerase chain reaction for detection of feline herpesvirus 1 in vaccinated and unvaccinated cats. Arch Virol 142:65-74.
  186. Sykes JE, Studdert VP, Browning GF. 1998. Detection and strain differentiation of feline calicivirus in conjunctival swabs by RT-PCR of the hypervariable region of the capsid protein gene. Arch Virol 143:1321-1334.
  187. Tajima T, Yoshizaki S, Nakata E, et al. 1998. Production of monoclonal antibody reacting broadly with feline calicivirus field isolates. J Vet Med Sci 60:155-160.
  188. Tenorio AP, Franti CE, Madewell BR, et al. 1991. Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses. Vet Immunol Immunopathol 29:1-14.
  189. TerWee T, Lauritzen A, Sabara M, et al. 1997. Comparison of the primary signs induced by experimental exposure to either a pneumotrophic or a "limping" strain of feline calicivirus. Vet Microbiol 56:33-45.
  190. Thiry E, Addie D, Belák S, et al. 2009. Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 11:547-555. Full guidelines available at http://www.abcd-vets.org/guidelines/index.asp. Accessed 5/21/11.
  191. Truyen U, Geissler K, Hirschberger J. 1999. Tissue distribution of virus replication in cats experimentally infected with distinct feline calicivirus isolates. Berl Munch Tierarztl Wochenschr 112:355-358.
  192. Turnquist SE, Ostlund E. 1997. Calicivirus outbreak with high mortality in a Missouri feline colony. J Vet Diagn Invest 9:195-198.
  193. Umehashi M, Imamura T, Akiyama, et al. 2002. Post-exposure treatment of cats with mouse-cat chimeric antibodies against feline herpesvirus type-1 and feline calicivirus. J Vet Med Sci 64:1017-1021.
  194. Umehashi M, Imamura T, Akiyama, et al. 2003. Pre-exposure treatment of cats with anti-FHV-1 and anti-FCV mouse-cat chimeric antibodies. J Vet Med Sci 65:563-566.
  195. van der Meulen K, Garré B, Croubels S, et al. 2006. In vitro comparison of antiviral drugs against feline herpesvirus 1. BMC Vet Res 2:13.
  196. van Vuuren M, Goosen T, Rogers P. 1999. Feline herpesvirus infection in a group of semi-captive cheetahs. J S Afr Vet Assoc 70:132-134.
  197. Veir JK, Ruch-Gallie R, Spindel ME, et al. 2008. Prevalence of selected infectious organisms and comparison of two anatomic sampling sites in shelter cats with upper respiratory tract disease. J Feline Med Surg 10:551-557.
  198. Vogtlin A, Fraefel C, Albini S, et al. 2002. Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR. J Clin Microbiol 40:519-523.
  199. Volopich S, Benetka V, Schendendwein I, et al. 2005. Cytologic findings, and feline herpesvirus DNA and Chlamydophila felis antigen detection rates in normal cats and cats with conjunctival and corneal lesions. Vet Ophthalmol 8: 25-32.
  200. Waters L, Hopper CD, Gruffydd-Jones TJ, et al. 1993. Chronic gingivitis in a colony of cats infected with feline immunodeficiency virus and feline calicivirus. Vet Rec 132:340-342.
  201. Weigler BJ, Babineau CA, Sherry B, et al. 1997. High sensitivity polymerase chain reaction assay for active and latent feline herpesvirus-1 infections in domestic cats. Vet Rec 140:335-338.
  202. Welsh RD. 1996. Bordetella bronchiseptica infections in cats. J Am Anim Hosp Assoc 32:153-158.
  203. Wheeler VJ. 2009. Unpublished observations, University of Liverpool, Liverpool, UK.
  204. Whitehead K, McCue KA. 2010. Virucidal efficacy of disinfectant actives against feline calicivirus, a surrogate for norovirus, in a short contact time. Am J Infect Control 38:26-30.
  205. Wilhelm S, Truyen U. 2006. Real-time reverse transcription polymerase chain reaction assay to detect a broad range of feline calicivirus isolates. J Virol Methods 133:105-108.
  206. Williams DL, Robinson JC, Lay E, et al. 2005. Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: results of a prospective clinical trial and data from in vitro investigations. Vet Rec 157:254-257.
  207. Williams J, Laris R, Gray AW, et al. 2002. Studies of the efficacy of a novel intranasal vaccine against feline bordetellosis. Vet Rec 150:439-442.
  208. Willoughby K, Bennett M, McCracken CM, et al. 1999. Molecular phylogenetic analysis of felid herpesvirus 1. Vet Microbiol 69:93-97.
  209. Yager JA, Hutchison L, Barrett JW. 2006. Raccoonpox in a Canadian cat. Vet Dermatol 17:443-448.
  210. Yokoyama N, Fujita K, Damiani A, et al. 1998. Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen. J Vet Med Sci 60:717-723.
  211. Zicola A, Saegerman C, Quatpers D, et al. 2009. Feline herpesvirus 1 and feline calicivirus infections in a heterogeneous cat population of a rescue shelter. J Feline Med Surg 11:1023-1027.